jte 522 has been researched along with Stomach Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirakawa, K; Nakazawa, K; Tendo, M; Yamada, N; Yashiro, M | 1 |
| Hirakawa, K; Nakazawa, K; Ohira, M; Sawada, T; Tendo, M; Yamada, N; Yashiro, M | 1 |
| Hirakawa, K; Kosaka, K; Nakazawa, K; Shinto, O; Tendo, M; Yashiro, M | 1 |
| Chen, DD; Li, HL; Li, XH; Lü, JH; Ren, XD; Wang, CC; Zhang, HW | 1 |
| Chen, DD; Li, HL; Li, XH; Lu, YQ; Ren, XD; Ye, CL; Zhang, HW | 1 |
5 other study(ies) available for jte 522 and Stomach Neoplasms
| Article | Year |
|---|---|
Inhibitory effect of a selective cyclooxygenase inhibitor on the invasion-stimulating activity of orthotopic fibroblasts for scirrhous gastric cancer cells.
Topics: Adenocarcinoma, Scirrhous; Animals; Antineoplastic Agents; Benzenesulfonates; Cell Line, Tumor; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Down-Regulation; Drug Synergism; Fibroblasts; Fluorouracil; Hepatocyte Growth Factor; Humans; In Vitro Techniques; Mice; Mice, Nude; Oxazoles; Prostaglandins E; Stomach Neoplasms | 2005 |
A synergic inhibitory-effect of combination with selective cyclooxygenase-2 inhibitor and S-1 on the peritoneal metastasis for scirrhous gastric cancer cells.
Topics: Adenocarcinoma, Scirrhous; Animals; Antimetabolites, Antineoplastic; Benzenesulfonates; Cyclooxygenase 2 Inhibitors; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Oxazoles; Oxonic Acid; Peritoneal Neoplasms; Stomach Neoplasms; Survival Rate; Tegafur; Tumor Cells, Cultured | 2006 |
Selective cyclooxygenase-2 inhibitor downregulates the paracrine epithelial-mesenchymal interactions of growth in scirrhous gastric carcinoma.
Topics: Animals; Benzenesulfonates; Cell Line; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Epithelial Cells; Female; Fibroblast Growth Factor 7; Fibroblasts; Humans; Immunoblotting; Immunohistochemistry; Mesoderm; Mice; Mice, Inbred BALB C; Mice, Nude; Oxazoles; Paracrine Communication; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stomach Neoplasms; Xenograft Model Antitumor Assays | 2007 |
JTE-522-induced apoptosis in human gastric adenocarcinoma [correction of adenocarcinoma] cell line AGS cells by caspase activation accompanying cytochrome C release, membrane translocation of Bax and loss of mitochondrial membrane potential.
Topics: Adenocarcinoma; Amino Acid Chloromethyl Ketones; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; bcl-2-Associated X Protein; Benzenesulfonates; Caspase Inhibitors; Caspases; Cyclooxygenase Inhibitors; Cysteine Proteinase Inhibitors; Cytochrome c Group; Enzyme Activation; Humans; In Situ Nick-End Labeling; Membrane Potentials; Mitochondria; Oxazoles; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Stomach Neoplasms; Tumor Cells, Cultured | 2002 |
Changes of NF-kB, p53, Bcl-2 and caspase in apoptosis induced by JTE-522 in human gastric adenocarcinoma cell line AGS cells: role of reactive oxygen species.
Topics: Adenocarcinoma; Apoptosis; Benzenesulfonates; Caspases; Cell Division; DNA-Binding Proteins; Humans; I-kappa B Proteins; NF-kappa B; NF-KappaB Inhibitor alpha; Oxazoles; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Stomach Neoplasms; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2002 |